There are nine upcoming IPOs this week, expected to raise a combined $627 million.
Leading the pack this week are biotech firm Cellectis (Nasdaq: CLLS) and solar panel producer SolarEdge Technologies Inc. (Nasdaq: SEDG).
by Alex McGuire
There are nine upcoming IPOs this week, expected to raise a combined $627 million.
Leading the pack this week are biotech firm Cellectis (Nasdaq: CLLS) and solar panel producer SolarEdge Technologies Inc. (Nasdaq: SEDG).
Here's a look at the rest of the upcoming IPOs on this week's IPO calendar...
by David Zeiler
The first DJIA stocks bore little resemblance to the Dow Jones Industrial Average stocks of today.
Most of the original DJIA stocks are completely unknown now.
The names paint a gritty picture of the U.S. corporate powers of the day. The very first DJIA stocks included two gas companies, two agricultural companies, and representatives from the chemical, steel, leather and rubber industries.
Today we've got three iconic stocks to short that aren't identifiable to everyone. Because there's only one reliable metric investors can use to recognize these seemingly pristine companies.
And our timing couldn't be better, since corporate profit growth is about to go negative and fears of another recession mount.
Here are the lucrative picks to profit from and why most investors are missing them...
by Sid Riggs
According to Bloomberg Business, people collectively waste an hour a day on Facebook debating everything from Kim Kardashian's hair to the now infamous gold/blue dress.
After last Wednesday, I've got to wonder how much time they're going to blow talking about what Fed Chair Janet Yellen said… or didn't.
At the end of the day it doesn't matter.
I say that because one of the most fundamental investing truisms of all is that "money moves to where it's treated best."
For the last six months, I have been warning that economic growth is faltering. In November of last year, I predicted that the U.S. economy would experience a "growth scare" in 2015.
This week, we learned that the Atlanta Fed is tracking first quarter GDP growth at a mere 0.3% and that the Federal Reserve's Open Market Committee (FOMC) has significantly downgraded its growth forecast.
We've got an outlook on tech stocks and a comprehensive outline on risk-management every investor should follow.
Plus, we've highlighted a half-dozen picks that will most certainly start you on your road to wealth.
by Jim Bach
For weeks now biotech stocks have headlined our list of top stocks to invest in for 2015.
And a particular biotech ETF is showing signals that this is rally is sector-wide, not confined to the smaller companies who get big lifts from specific price catalysts.
Here's why biotech stocks are so hot in 2015, and what this biotech ETF is telling us...
The Dow Jones Industrial Average reversed a streak of three consecutive weekly losses and added 201 points on Friday.
Why the gain? Declining dollar raised corporate earnings enthusiasm, while the markets got a boost from Nike Corp. (NYSE: NKE) earnings and exciting news in biotech.
Here are the day's top market stories, plus our new profit tip for investors...
Wearable tech, medical tech, and cybersecurity are three of the most promising tech sectors we like investing in today. And all of those fields were the stars of the South by Southwest (SXSW) Interactive 2015 festival in Austin, Texas, this week.
Tech innovations are on full display at the festival's exhibition halls, where nearly 600 exhibit spaces are rented. In just four days, more than 65,000 people file through dozens of aisle ways to see demonstrations and product unveilings from robotics, virtual reality, gaming, and more.
SXSW sounds like it's mostly for tech junkies, but it's a treasure trove of profit opportunities for investors. It points to where the money will flow.
by David Zeiler
Federal Reserve Chairwoman Janet Yellen topped the news this week – but she didn't actually say anything…
And the markets went wild Wednesday trying to parse Yellen's remarks and the language of the latest FOMC meeting policy statement.
Yellen's word games mess with how markets are supposed to operate. It leaves investors guessing about what's ahead.